Goldman Sachs Initiates Coverage On Bill.com Holdings with Buy Rating, Announces Price Target of $296
Goldman Sachs analyst Will Nance initiates coverage on Bill.com Holdings (NYSE:BILL) with a Buy rating and announces Price Target of $296.
45 Stocks Moving In Monday’s Mid-Day Session
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88.
Expert Ratings For Bill.com Holdings
Within the last quarter, Bill.com Holdings (NYSE:BILL) has observed the following analyst ratings:
Keefe, Bruyette & Woods Initiates Coverage On Bill.com Holdings with Outperform Rating, Announces Price Target of $300
Keefe, Bruyette & Woods analyst Sanjay Sakhrani initiates coverage on Bill.com Holdings (NYSE:BILL) with a Outperform rating and announces Price Target of $300.
Director Of Bill.Com Holdings Trades $3.5M In Company Stock
Allison Mnookin, Director at Bill.Com Holdings (NYSE:BILL), made a large buy and sell of company shares on November 8, according to a new SEC filing.
Bill.com Shares Soar As Analysts Bump Up Price Targets
Analysts bumped up price targets on Bill.com Holdings (NYSE:BILL) following upbeat Q1 FY22 results. Canaccord analyst Joseph Vafi raised the price target to…
Expert Ratings For Bill.com Holdings
Bill.com Holdings (NYSE:BILL) has observed the following analyst ratings within the last quarter: